Table 1. Clinical Characteristics.
| Age, years, mean (SD) | 59 | (16) |
| Male, n | 7 | |
| Initial rhythm, n | ||
| Shockable (VF/VT) | 3 | |
| Non-shockable (bradycardia/asystole/PEA) | 7 | |
| Primary cause of CPR, n (%) | ||
| Cardiac | 3 | |
| Hypoxic | 6 | |
| Unknown | 1 | |
| Location of arrest, n | ||
| OHCA | 8 | |
| IHCA | 2 | |
| Time to ROSC (minutes), median (IQR) | 18 | (10–23) |
| Time to occurrence of PAM (hours), median (IQR) | 14 | (10–36) |
| Initial treatment of PAM, n | ||
| Propofol | 8 | |
| Clonazepam | 3 | |
| Sodium valproate | 3 | |
| Levetiracetam | 2 | |
| Other benzodiazepine | 2 | |
| >1 drug | 4 | |
| SEP N20, n | ||
| Present | 5 | |
| Bilaterally absent | 5 | |
| EEG result, n | ||
| Normal/mild encephalopathic | 0 | |
| Diffuse slowing | 1 | |
| Status epilepticus | 4 | |
| Burst suppression | 4 | |
| Low voltage/isoelectric | 0 | |
| No EEG | 1 | |
| Outcome, n | ||
| Recovery with mild cerebral disability | 1 | |
| Death | 9 | |
| Treatment withdrawal, n | 9 | |
| Time to treatment withdrawal (hours), median (IQR) | 48 | (38–130) |
| Reason for treatment withdrawal, n | ||
| Neurological examination | 4 | |
| SEP | 5 | |
| EEG | 5 | |
| Combination | 3 |
Abbreviations: CPR, Cardiopulmonary Resuscitation; EEG, Electroencephalography; ICU, Intensive Care Unit; IHCA, In Hospital Cardiac Arrest; IQR, Interquartile Range; OHCA, Out of Hospital Cardiac Arrest; PAM, Post-anoxic Myoclonus; PEA, Pulseless Electrical Activity; ROSC, Return of Spontaneous Circulation; SD, Standard Deviation; SEP, Somatosensory Evoked Potential; VF, Ventricular Fibrillation; VT, Ventricular Tachycardia.